Cargando…
PERIPHERAL NERVE BLOCKS IN PATIENTS ON ANTITHROMBOTIC DRUGS – A RESCUE OR AN UNNECESSARY RISK?
Bleeding complications after peripheral nerve blocks (PNBs) in patients treated with an antiplatelet agent and/or an anticoagulant drug are rare, with estimated incidence of 0.67% (0.51–0.83%). However, they can result in significant patient morbidity and may require follow-up investigations and int...
Autor principal: | Poredoš, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942461/ https://www.ncbi.nlm.nih.gov/pubmed/36824631 http://dx.doi.org/10.20471/acc.2022.61.s2.08 |
Ejemplares similares
-
Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutions
por: Li, Jinlei, et al.
Publicado: (2015) -
Dexmedetomidine as an Adjuvant in Peripheral Nerve Block
por: Chen, Zheping, et al.
Publicado: (2023) -
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
The Role of Continuous Peripheral Nerve Blocks
por: Aguirre, José, et al.
Publicado: (2012) -
Dry Needling and Antithrombotic Drugs
por: Muñoz, María, et al.
Publicado: (2022)